nodes	percent_of_prediction	percent_of_DWPC	metapath
Rotigotine—Parkinson's disease—Bromocriptine—type 2 diabetes mellitus	0.356	1	CpDpCtD
Rotigotine—CYP1A2—type 2 diabetes mellitus	0.111	0.602	CbGaD
Rotigotine—CYP3A4—type 2 diabetes mellitus	0.0732	0.398	CbGaD
Rotigotine—DRD5—Bromocriptine—type 2 diabetes mellitus	0.0508	0.165	CbGbCtD
Rotigotine—DRD4—Bromocriptine—type 2 diabetes mellitus	0.0362	0.117	CbGbCtD
Rotigotine—DRD3—Bromocriptine—type 2 diabetes mellitus	0.0269	0.0873	CbGbCtD
Rotigotine—DRD1—Bromocriptine—type 2 diabetes mellitus	0.0259	0.0841	CbGbCtD
Rotigotine—ADRA2B—Bromocriptine—type 2 diabetes mellitus	0.0246	0.0798	CbGbCtD
Rotigotine—HTR1A—Bromocriptine—type 2 diabetes mellitus	0.0179	0.058	CbGbCtD
Rotigotine—DRD2—Bromocriptine—type 2 diabetes mellitus	0.0158	0.0511	CbGbCtD
Rotigotine—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.00928	0.0301	CbGbCtD
Rotigotine—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.00828	0.0269	CbGbCtD
Rotigotine—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.00817	0.0265	CbGbCtD
Rotigotine—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.00764	0.0248	CbGbCtD
Rotigotine—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.0073	0.0237	CbGbCtD
Rotigotine—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.00728	0.0236	CbGbCtD
Rotigotine—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.00691	0.0224	CbGbCtD
Rotigotine—CYP3A4—Glipizide—type 2 diabetes mellitus	0.00666	0.0216	CbGbCtD
Rotigotine—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.00628	0.0204	CbGbCtD
Rotigotine—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.00602	0.0195	CbGbCtD
Rotigotine—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00582	0.0189	CbGbCtD
Rotigotine—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00527	0.0171	CbGbCtD
Rotigotine—CYP1A2—Losartan—type 2 diabetes mellitus	0.00471	0.0153	CbGbCtD
Rotigotine—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00399	0.013	CbGbCtD
Rotigotine—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00383	0.0124	CbGbCtD
Rotigotine—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00383	0.0124	CbGbCtD
Rotigotine—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00362	0.0117	CbGbCtD
Rotigotine—CYP3A4—Glyburide—type 2 diabetes mellitus	0.0027	0.00875	CbGbCtD
Rotigotine—CYP3A4—Losartan—type 2 diabetes mellitus	0.00247	0.008	CbGbCtD
Rotigotine—Urticaria—Glyburide—type 2 diabetes mellitus	7.12e-05	0.000699	CcSEcCtD
Rotigotine—Angioedema—Irbesartan—type 2 diabetes mellitus	7.11e-05	0.000698	CcSEcCtD
Rotigotine—Oedema peripheral—Ramipril—type 2 diabetes mellitus	7.11e-05	0.000698	CcSEcCtD
Rotigotine—Skin disorder—Orlistat—type 2 diabetes mellitus	7.1e-05	0.000696	CcSEcCtD
Rotigotine—Connective tissue disorder—Ramipril—type 2 diabetes mellitus	7.09e-05	0.000696	CcSEcCtD
Rotigotine—Dyspepsia—Gliclazide—type 2 diabetes mellitus	7.08e-05	0.000695	CcSEcCtD
Rotigotine—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	7.06e-05	0.000693	CcSEcCtD
Rotigotine—Anorexia—Valsartan—type 2 diabetes mellitus	7.05e-05	0.000692	CcSEcCtD
Rotigotine—Muscle spasms—Losartan—type 2 diabetes mellitus	7.05e-05	0.000691	CcSEcCtD
Rotigotine—Asthenia—Bromocriptine—type 2 diabetes mellitus	7.03e-05	0.00069	CcSEcCtD
Rotigotine—Malaise—Irbesartan—type 2 diabetes mellitus	7.02e-05	0.000689	CcSEcCtD
Rotigotine—Vertigo—Irbesartan—type 2 diabetes mellitus	7e-05	0.000686	CcSEcCtD
Rotigotine—Headache—Pioglitazone—type 2 diabetes mellitus	6.99e-05	0.000686	CcSEcCtD
Rotigotine—Syncope—Irbesartan—type 2 diabetes mellitus	6.98e-05	0.000685	CcSEcCtD
Rotigotine—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	6.98e-05	0.000684	CcSEcCtD
Rotigotine—Visual impairment—Ramipril—type 2 diabetes mellitus	6.96e-05	0.000682	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	6.95e-05	0.000682	CcSEcCtD
Rotigotine—Discomfort—Metformin—type 2 diabetes mellitus	6.94e-05	0.000681	CcSEcCtD
Rotigotine—Fatigue—Gliclazide—type 2 diabetes mellitus	6.94e-05	0.000681	CcSEcCtD
Rotigotine—Nausea—Glipizide—type 2 diabetes mellitus	6.92e-05	0.000679	CcSEcCtD
Rotigotine—Vomiting—Glimepiride—type 2 diabetes mellitus	6.91e-05	0.000678	CcSEcCtD
Rotigotine—Hypotension—Valsartan—type 2 diabetes mellitus	6.91e-05	0.000678	CcSEcCtD
Rotigotine—Vomiting—Sitagliptin—type 2 diabetes mellitus	6.89e-05	0.000676	CcSEcCtD
Rotigotine—Pain—Gliclazide—type 2 diabetes mellitus	6.88e-05	0.000675	CcSEcCtD
Rotigotine—Constipation—Gliclazide—type 2 diabetes mellitus	6.88e-05	0.000675	CcSEcCtD
Rotigotine—Tremor—Losartan—type 2 diabetes mellitus	6.87e-05	0.000674	CcSEcCtD
Rotigotine—Rash—Glimepiride—type 2 diabetes mellitus	6.85e-05	0.000672	CcSEcCtD
Rotigotine—Dermatitis—Glimepiride—type 2 diabetes mellitus	6.85e-05	0.000672	CcSEcCtD
Rotigotine—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	6.84e-05	0.000671	CcSEcCtD
Rotigotine—Rash—Sitagliptin—type 2 diabetes mellitus	6.83e-05	0.00067	CcSEcCtD
Rotigotine—Dermatitis—Sitagliptin—type 2 diabetes mellitus	6.83e-05	0.00067	CcSEcCtD
Rotigotine—Headache—Glimepiride—type 2 diabetes mellitus	6.81e-05	0.000668	CcSEcCtD
Rotigotine—Ill-defined disorder—Losartan—type 2 diabetes mellitus	6.8e-05	0.000667	CcSEcCtD
Rotigotine—Cough—Irbesartan—type 2 diabetes mellitus	6.79e-05	0.000667	CcSEcCtD
Rotigotine—Headache—Sitagliptin—type 2 diabetes mellitus	6.79e-05	0.000666	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	6.74e-05	0.000661	CcSEcCtD
Rotigotine—Agitation—Losartan—type 2 diabetes mellitus	6.73e-05	0.000661	CcSEcCtD
Rotigotine—Tinnitus—Ramipril—type 2 diabetes mellitus	6.73e-05	0.00066	CcSEcCtD
Rotigotine—Hypertension—Irbesartan—type 2 diabetes mellitus	6.72e-05	0.00066	CcSEcCtD
Rotigotine—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	6.71e-05	0.000658	CcSEcCtD
Rotigotine—Angioedema—Losartan—type 2 diabetes mellitus	6.7e-05	0.000657	CcSEcCtD
Rotigotine—Infection—Metformin—type 2 diabetes mellitus	6.69e-05	0.000656	CcSEcCtD
Rotigotine—Insomnia—Valsartan—type 2 diabetes mellitus	6.69e-05	0.000656	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	6.66e-05	0.000653	CcSEcCtD
Rotigotine—Paraesthesia—Valsartan—type 2 diabetes mellitus	6.64e-05	0.000651	CcSEcCtD
Rotigotine—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	6.63e-05	0.000651	CcSEcCtD
Rotigotine—Arthralgia—Irbesartan—type 2 diabetes mellitus	6.63e-05	0.00065	CcSEcCtD
Rotigotine—Shock—Metformin—type 2 diabetes mellitus	6.63e-05	0.00065	CcSEcCtD
Rotigotine—Insomnia—Orlistat—type 2 diabetes mellitus	6.61e-05	0.000648	CcSEcCtD
Rotigotine—Malaise—Losartan—type 2 diabetes mellitus	6.61e-05	0.000648	CcSEcCtD
Rotigotine—Hypersensitivity—Glyburide—type 2 diabetes mellitus	6.6e-05	0.000648	CcSEcCtD
Rotigotine—Nervous system disorder—Metformin—type 2 diabetes mellitus	6.6e-05	0.000648	CcSEcCtD
Rotigotine—Vertigo—Losartan—type 2 diabetes mellitus	6.58e-05	0.000646	CcSEcCtD
Rotigotine—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	6.58e-05	0.000646	CcSEcCtD
Rotigotine—Somnolence—Valsartan—type 2 diabetes mellitus	6.57e-05	0.000645	CcSEcCtD
Rotigotine—Syncope—Losartan—type 2 diabetes mellitus	6.57e-05	0.000645	CcSEcCtD
Rotigotine—Paraesthesia—Orlistat—type 2 diabetes mellitus	6.56e-05	0.000644	CcSEcCtD
Rotigotine—Discomfort—Irbesartan—type 2 diabetes mellitus	6.55e-05	0.000643	CcSEcCtD
Rotigotine—Skin disorder—Metformin—type 2 diabetes mellitus	6.54e-05	0.000642	CcSEcCtD
Rotigotine—Immune system disorder—Ramipril—type 2 diabetes mellitus	6.52e-05	0.00064	CcSEcCtD
Rotigotine—Hyperhidrosis—Metformin—type 2 diabetes mellitus	6.51e-05	0.000639	CcSEcCtD
Rotigotine—Dyspepsia—Valsartan—type 2 diabetes mellitus	6.51e-05	0.000639	CcSEcCtD
Rotigotine—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	6.51e-05	0.000638	CcSEcCtD
Rotigotine—Dizziness—Bromocriptine—type 2 diabetes mellitus	6.48e-05	0.000636	CcSEcCtD
Rotigotine—Dry mouth—Irbesartan—type 2 diabetes mellitus	6.48e-05	0.000636	CcSEcCtD
Rotigotine—Nausea—Glimepiride—type 2 diabetes mellitus	6.46e-05	0.000633	CcSEcCtD
Rotigotine—Loss of consciousness—Losartan—type 2 diabetes mellitus	6.44e-05	0.000632	CcSEcCtD
Rotigotine—Nausea—Sitagliptin—type 2 diabetes mellitus	6.44e-05	0.000631	CcSEcCtD
Rotigotine—Dyspepsia—Orlistat—type 2 diabetes mellitus	6.43e-05	0.000631	CcSEcCtD
Rotigotine—Asthenia—Glyburide—type 2 diabetes mellitus	6.43e-05	0.000631	CcSEcCtD
Rotigotine—Decreased appetite—Valsartan—type 2 diabetes mellitus	6.43e-05	0.000631	CcSEcCtD
Rotigotine—Anorexia—Metformin—type 2 diabetes mellitus	6.42e-05	0.00063	CcSEcCtD
Rotigotine—Cough—Losartan—type 2 diabetes mellitus	6.39e-05	0.000627	CcSEcCtD
Rotigotine—Urticaria—Gliclazide—type 2 diabetes mellitus	6.39e-05	0.000627	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	6.38e-05	0.000626	CcSEcCtD
Rotigotine—Fatigue—Valsartan—type 2 diabetes mellitus	6.38e-05	0.000625	CcSEcCtD
Rotigotine—Decreased appetite—Orlistat—type 2 diabetes mellitus	6.35e-05	0.000623	CcSEcCtD
Rotigotine—Pruritus—Glyburide—type 2 diabetes mellitus	6.34e-05	0.000622	CcSEcCtD
Rotigotine—Mental disorder—Ramipril—type 2 diabetes mellitus	6.32e-05	0.00062	CcSEcCtD
Rotigotine—Constipation—Valsartan—type 2 diabetes mellitus	6.32e-05	0.00062	CcSEcCtD
Rotigotine—Infection—Irbesartan—type 2 diabetes mellitus	6.31e-05	0.000619	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	6.31e-05	0.000619	CcSEcCtD
Rotigotine—Fatigue—Orlistat—type 2 diabetes mellitus	6.3e-05	0.000618	CcSEcCtD
Rotigotine—Hypotension—Metformin—type 2 diabetes mellitus	6.29e-05	0.000617	CcSEcCtD
Rotigotine—Erythema—Ramipril—type 2 diabetes mellitus	6.28e-05	0.000616	CcSEcCtD
Rotigotine—Malnutrition—Ramipril—type 2 diabetes mellitus	6.28e-05	0.000616	CcSEcCtD
Rotigotine—Shock—Irbesartan—type 2 diabetes mellitus	6.25e-05	0.000613	CcSEcCtD
Rotigotine—Pain—Orlistat—type 2 diabetes mellitus	6.25e-05	0.000613	CcSEcCtD
Rotigotine—Arthralgia—Losartan—type 2 diabetes mellitus	6.24e-05	0.000612	CcSEcCtD
Rotigotine—Vomiting—Bromocriptine—type 2 diabetes mellitus	6.23e-05	0.000612	CcSEcCtD
Rotigotine—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	6.23e-05	0.000611	CcSEcCtD
Rotigotine—Rash—Bromocriptine—type 2 diabetes mellitus	6.18e-05	0.000607	CcSEcCtD
Rotigotine—Dermatitis—Bromocriptine—type 2 diabetes mellitus	6.18e-05	0.000606	CcSEcCtD
Rotigotine—Skin disorder—Irbesartan—type 2 diabetes mellitus	6.17e-05	0.000606	CcSEcCtD
Rotigotine—Discomfort—Losartan—type 2 diabetes mellitus	6.16e-05	0.000605	CcSEcCtD
Rotigotine—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	6.14e-05	0.000603	CcSEcCtD
Rotigotine—Headache—Bromocriptine—type 2 diabetes mellitus	6.14e-05	0.000603	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	6.14e-05	0.000602	CcSEcCtD
Rotigotine—Diarrhoea—Glyburide—type 2 diabetes mellitus	6.13e-05	0.000602	CcSEcCtD
Rotigotine—Dry mouth—Losartan—type 2 diabetes mellitus	6.1e-05	0.000599	CcSEcCtD
Rotigotine—Anorexia—Irbesartan—type 2 diabetes mellitus	6.06e-05	0.000594	CcSEcCtD
Rotigotine—Paraesthesia—Metformin—type 2 diabetes mellitus	6.05e-05	0.000593	CcSEcCtD
Rotigotine—Muscle spasms—Ramipril—type 2 diabetes mellitus	6.04e-05	0.000593	CcSEcCtD
Rotigotine—Confusional state—Losartan—type 2 diabetes mellitus	6.03e-05	0.000592	CcSEcCtD
Rotigotine—Feeling abnormal—Orlistat—type 2 diabetes mellitus	6.02e-05	0.000591	CcSEcCtD
Rotigotine—Somnolence—Metformin—type 2 diabetes mellitus	5.99e-05	0.000587	CcSEcCtD
Rotigotine—Infection—Losartan—type 2 diabetes mellitus	5.94e-05	0.000583	CcSEcCtD
Rotigotine—Hypotension—Irbesartan—type 2 diabetes mellitus	5.94e-05	0.000583	CcSEcCtD
Rotigotine—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	5.93e-05	0.000582	CcSEcCtD
Rotigotine—Dyspepsia—Metformin—type 2 diabetes mellitus	5.93e-05	0.000582	CcSEcCtD
Rotigotine—Tremor—Ramipril—type 2 diabetes mellitus	5.89e-05	0.000578	CcSEcCtD
Rotigotine—Shock—Losartan—type 2 diabetes mellitus	5.88e-05	0.000577	CcSEcCtD
Rotigotine—Urticaria—Valsartan—type 2 diabetes mellitus	5.87e-05	0.000576	CcSEcCtD
Rotigotine—Nervous system disorder—Losartan—type 2 diabetes mellitus	5.87e-05	0.000575	CcSEcCtD
Rotigotine—Decreased appetite—Metformin—type 2 diabetes mellitus	5.85e-05	0.000574	CcSEcCtD
Rotigotine—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	5.83e-05	0.000572	CcSEcCtD
Rotigotine—Nausea—Bromocriptine—type 2 diabetes mellitus	5.82e-05	0.000571	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	5.81e-05	0.00057	CcSEcCtD
Rotigotine—Fatigue—Metformin—type 2 diabetes mellitus	5.81e-05	0.00057	CcSEcCtD
Rotigotine—Urticaria—Orlistat—type 2 diabetes mellitus	5.8e-05	0.000569	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	5.79e-05	0.000568	CcSEcCtD
Rotigotine—Hyperhidrosis—Losartan—type 2 diabetes mellitus	5.78e-05	0.000567	CcSEcCtD
Rotigotine—Asthenia—Gliclazide—type 2 diabetes mellitus	5.77e-05	0.000567	CcSEcCtD
Rotigotine—Agitation—Ramipril—type 2 diabetes mellitus	5.77e-05	0.000566	CcSEcCtD
Rotigotine—Constipation—Metformin—type 2 diabetes mellitus	5.76e-05	0.000565	CcSEcCtD
Rotigotine—Angioedema—Ramipril—type 2 diabetes mellitus	5.74e-05	0.000563	CcSEcCtD
Rotigotine—Paraesthesia—Irbesartan—type 2 diabetes mellitus	5.71e-05	0.00056	CcSEcCtD
Rotigotine—Anorexia—Losartan—type 2 diabetes mellitus	5.7e-05	0.000559	CcSEcCtD
Rotigotine—Vomiting—Glyburide—type 2 diabetes mellitus	5.7e-05	0.000559	CcSEcCtD
Rotigotine—Pruritus—Gliclazide—type 2 diabetes mellitus	5.69e-05	0.000559	CcSEcCtD
Rotigotine—Malaise—Ramipril—type 2 diabetes mellitus	5.67e-05	0.000556	CcSEcCtD
Rotigotine—Rash—Glyburide—type 2 diabetes mellitus	5.65e-05	0.000554	CcSEcCtD
Rotigotine—Somnolence—Irbesartan—type 2 diabetes mellitus	5.65e-05	0.000554	CcSEcCtD
Rotigotine—Dermatitis—Glyburide—type 2 diabetes mellitus	5.65e-05	0.000554	CcSEcCtD
Rotigotine—Vertigo—Ramipril—type 2 diabetes mellitus	5.65e-05	0.000554	CcSEcCtD
Rotigotine—Syncope—Ramipril—type 2 diabetes mellitus	5.63e-05	0.000553	CcSEcCtD
Rotigotine—Headache—Glyburide—type 2 diabetes mellitus	5.62e-05	0.000551	CcSEcCtD
Rotigotine—Dyspepsia—Irbesartan—type 2 diabetes mellitus	5.59e-05	0.000549	CcSEcCtD
Rotigotine—Hypotension—Losartan—type 2 diabetes mellitus	5.59e-05	0.000548	CcSEcCtD
Rotigotine—Feeling abnormal—Metformin—type 2 diabetes mellitus	5.55e-05	0.000544	CcSEcCtD
Rotigotine—Decreased appetite—Irbesartan—type 2 diabetes mellitus	5.52e-05	0.000542	CcSEcCtD
Rotigotine—Loss of consciousness—Ramipril—type 2 diabetes mellitus	5.52e-05	0.000542	CcSEcCtD
Rotigotine—Diarrhoea—Gliclazide—type 2 diabetes mellitus	5.51e-05	0.00054	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	5.49e-05	0.000538	CcSEcCtD
Rotigotine—Cough—Ramipril—type 2 diabetes mellitus	5.48e-05	0.000538	CcSEcCtD
Rotigotine—Fatigue—Irbesartan—type 2 diabetes mellitus	5.48e-05	0.000538	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	5.45e-05	0.000535	CcSEcCtD
Rotigotine—Hypersensitivity—Valsartan—type 2 diabetes mellitus	5.45e-05	0.000534	CcSEcCtD
Rotigotine—Constipation—Irbesartan—type 2 diabetes mellitus	5.43e-05	0.000533	CcSEcCtD
Rotigotine—Pain—Irbesartan—type 2 diabetes mellitus	5.43e-05	0.000533	CcSEcCtD
Rotigotine—Insomnia—Losartan—type 2 diabetes mellitus	5.41e-05	0.000531	CcSEcCtD
Rotigotine—Hypersensitivity—Orlistat—type 2 diabetes mellitus	5.38e-05	0.000528	CcSEcCtD
Rotigotine—Paraesthesia—Losartan—type 2 diabetes mellitus	5.37e-05	0.000527	CcSEcCtD
Rotigotine—Urticaria—Metformin—type 2 diabetes mellitus	5.35e-05	0.000525	CcSEcCtD
Rotigotine—Arthralgia—Ramipril—type 2 diabetes mellitus	5.35e-05	0.000525	CcSEcCtD
Rotigotine—Nausea—Glyburide—type 2 diabetes mellitus	5.32e-05	0.000522	CcSEcCtD
Rotigotine—Dizziness—Gliclazide—type 2 diabetes mellitus	5.32e-05	0.000522	CcSEcCtD
Rotigotine—Somnolence—Losartan—type 2 diabetes mellitus	5.32e-05	0.000522	CcSEcCtD
Rotigotine—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	5.31e-05	0.000521	CcSEcCtD
Rotigotine—Asthenia—Valsartan—type 2 diabetes mellitus	5.31e-05	0.00052	CcSEcCtD
Rotigotine—Discomfort—Ramipril—type 2 diabetes mellitus	5.29e-05	0.000519	CcSEcCtD
Rotigotine—Dyspepsia—Losartan—type 2 diabetes mellitus	5.26e-05	0.000516	CcSEcCtD
Rotigotine—Asthenia—Orlistat—type 2 diabetes mellitus	5.24e-05	0.000514	CcSEcCtD
Rotigotine—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	5.24e-05	0.000514	CcSEcCtD
Rotigotine—Pruritus—Valsartan—type 2 diabetes mellitus	5.23e-05	0.000513	CcSEcCtD
Rotigotine—Dry mouth—Ramipril—type 2 diabetes mellitus	5.23e-05	0.000513	CcSEcCtD
Rotigotine—Decreased appetite—Losartan—type 2 diabetes mellitus	5.2e-05	0.00051	CcSEcCtD
Rotigotine—Confusional state—Ramipril—type 2 diabetes mellitus	5.17e-05	0.000507	CcSEcCtD
Rotigotine—Pruritus—Orlistat—type 2 diabetes mellitus	5.17e-05	0.000507	CcSEcCtD
Rotigotine—Fatigue—Losartan—type 2 diabetes mellitus	5.16e-05	0.000506	CcSEcCtD
Rotigotine—Vomiting—Gliclazide—type 2 diabetes mellitus	5.12e-05	0.000502	CcSEcCtD
Rotigotine—Constipation—Losartan—type 2 diabetes mellitus	5.11e-05	0.000502	CcSEcCtD
Rotigotine—Pain—Losartan—type 2 diabetes mellitus	5.11e-05	0.000502	CcSEcCtD
Rotigotine—Rash—Gliclazide—type 2 diabetes mellitus	5.07e-05	0.000498	CcSEcCtD
Rotigotine—Dermatitis—Gliclazide—type 2 diabetes mellitus	5.07e-05	0.000497	CcSEcCtD
Rotigotine—Diarrhoea—Valsartan—type 2 diabetes mellitus	5.06e-05	0.000496	CcSEcCtD
Rotigotine—Urticaria—Irbesartan—type 2 diabetes mellitus	5.05e-05	0.000495	CcSEcCtD
Rotigotine—Shock—Ramipril—type 2 diabetes mellitus	5.05e-05	0.000495	CcSEcCtD
Rotigotine—Headache—Gliclazide—type 2 diabetes mellitus	5.04e-05	0.000495	CcSEcCtD
Rotigotine—Nervous system disorder—Ramipril—type 2 diabetes mellitus	5.03e-05	0.000493	CcSEcCtD
Rotigotine—Diarrhoea—Orlistat—type 2 diabetes mellitus	5e-05	0.00049	CcSEcCtD
Rotigotine—Skin disorder—Ramipril—type 2 diabetes mellitus	4.98e-05	0.000489	CcSEcCtD
Rotigotine—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	4.96e-05	0.000486	CcSEcCtD
Rotigotine—Feeling abnormal—Losartan—type 2 diabetes mellitus	4.93e-05	0.000483	CcSEcCtD
Rotigotine—Dizziness—Valsartan—type 2 diabetes mellitus	4.89e-05	0.00048	CcSEcCtD
Rotigotine—Anorexia—Ramipril—type 2 diabetes mellitus	4.89e-05	0.00048	CcSEcCtD
Rotigotine—Dizziness—Orlistat—type 2 diabetes mellitus	4.83e-05	0.000474	CcSEcCtD
Rotigotine—Asthenia—Metformin—type 2 diabetes mellitus	4.83e-05	0.000474	CcSEcCtD
Rotigotine—Hypotension—Ramipril—type 2 diabetes mellitus	4.79e-05	0.00047	CcSEcCtD
Rotigotine—Nausea—Gliclazide—type 2 diabetes mellitus	4.78e-05	0.000469	CcSEcCtD
Rotigotine—Pruritus—Metformin—type 2 diabetes mellitus	4.76e-05	0.000467	CcSEcCtD
Rotigotine—Urticaria—Losartan—type 2 diabetes mellitus	4.75e-05	0.000466	CcSEcCtD
Rotigotine—Vomiting—Valsartan—type 2 diabetes mellitus	4.7e-05	0.000461	CcSEcCtD
Rotigotine—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	4.68e-05	0.000459	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	4.67e-05	0.000458	CcSEcCtD
Rotigotine—Rash—Valsartan—type 2 diabetes mellitus	4.66e-05	0.000457	CcSEcCtD
Rotigotine—Dermatitis—Valsartan—type 2 diabetes mellitus	4.66e-05	0.000457	CcSEcCtD
Rotigotine—Vomiting—Orlistat—type 2 diabetes mellitus	4.65e-05	0.000456	CcSEcCtD
Rotigotine—Insomnia—Ramipril—type 2 diabetes mellitus	4.64e-05	0.000455	CcSEcCtD
Rotigotine—Headache—Valsartan—type 2 diabetes mellitus	4.63e-05	0.000454	CcSEcCtD
Rotigotine—Diarrhoea—Metformin—type 2 diabetes mellitus	4.61e-05	0.000452	CcSEcCtD
Rotigotine—Rash—Orlistat—type 2 diabetes mellitus	4.61e-05	0.000452	CcSEcCtD
Rotigotine—Paraesthesia—Ramipril—type 2 diabetes mellitus	4.6e-05	0.000452	CcSEcCtD
Rotigotine—Dermatitis—Orlistat—type 2 diabetes mellitus	4.6e-05	0.000452	CcSEcCtD
Rotigotine—Headache—Orlistat—type 2 diabetes mellitus	4.58e-05	0.000449	CcSEcCtD
Rotigotine—Asthenia—Irbesartan—type 2 diabetes mellitus	4.56e-05	0.000447	CcSEcCtD
Rotigotine—Somnolence—Ramipril—type 2 diabetes mellitus	4.56e-05	0.000447	CcSEcCtD
Rotigotine—Dyspepsia—Ramipril—type 2 diabetes mellitus	4.51e-05	0.000443	CcSEcCtD
Rotigotine—Pruritus—Irbesartan—type 2 diabetes mellitus	4.5e-05	0.000441	CcSEcCtD
Rotigotine—Decreased appetite—Ramipril—type 2 diabetes mellitus	4.46e-05	0.000437	CcSEcCtD
Rotigotine—Dizziness—Metformin—type 2 diabetes mellitus	4.45e-05	0.000437	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	4.43e-05	0.000434	CcSEcCtD
Rotigotine—Fatigue—Ramipril—type 2 diabetes mellitus	4.42e-05	0.000434	CcSEcCtD
Rotigotine—Hypersensitivity—Losartan—type 2 diabetes mellitus	4.41e-05	0.000432	CcSEcCtD
Rotigotine—Nausea—Valsartan—type 2 diabetes mellitus	4.39e-05	0.000431	CcSEcCtD
Rotigotine—Constipation—Ramipril—type 2 diabetes mellitus	4.39e-05	0.00043	CcSEcCtD
Rotigotine—Diarrhoea—Irbesartan—type 2 diabetes mellitus	4.35e-05	0.000427	CcSEcCtD
Rotigotine—Nausea—Orlistat—type 2 diabetes mellitus	4.34e-05	0.000426	CcSEcCtD
Rotigotine—Asthenia—Losartan—type 2 diabetes mellitus	4.29e-05	0.000421	CcSEcCtD
Rotigotine—Vomiting—Metformin—type 2 diabetes mellitus	4.28e-05	0.00042	CcSEcCtD
Rotigotine—Rash—Metformin—type 2 diabetes mellitus	4.25e-05	0.000417	CcSEcCtD
Rotigotine—Dermatitis—Metformin—type 2 diabetes mellitus	4.24e-05	0.000416	CcSEcCtD
Rotigotine—Pruritus—Losartan—type 2 diabetes mellitus	4.23e-05	0.000415	CcSEcCtD
Rotigotine—Feeling abnormal—Ramipril—type 2 diabetes mellitus	4.23e-05	0.000415	CcSEcCtD
Rotigotine—Headache—Metformin—type 2 diabetes mellitus	4.22e-05	0.000414	CcSEcCtD
Rotigotine—Dizziness—Irbesartan—type 2 diabetes mellitus	4.2e-05	0.000412	CcSEcCtD
Rotigotine—Diarrhoea—Losartan—type 2 diabetes mellitus	4.09e-05	0.000401	CcSEcCtD
Rotigotine—Urticaria—Ramipril—type 2 diabetes mellitus	4.07e-05	0.0004	CcSEcCtD
Rotigotine—Vomiting—Irbesartan—type 2 diabetes mellitus	4.04e-05	0.000396	CcSEcCtD
Rotigotine—Rash—Irbesartan—type 2 diabetes mellitus	4.01e-05	0.000393	CcSEcCtD
Rotigotine—Dermatitis—Irbesartan—type 2 diabetes mellitus	4e-05	0.000393	CcSEcCtD
Rotigotine—Nausea—Metformin—type 2 diabetes mellitus	4e-05	0.000392	CcSEcCtD
Rotigotine—Headache—Irbesartan—type 2 diabetes mellitus	3.98e-05	0.000391	CcSEcCtD
Rotigotine—Dizziness—Losartan—type 2 diabetes mellitus	3.95e-05	0.000388	CcSEcCtD
Rotigotine—Vomiting—Losartan—type 2 diabetes mellitus	3.8e-05	0.000373	CcSEcCtD
Rotigotine—Hypersensitivity—Ramipril—type 2 diabetes mellitus	3.78e-05	0.000371	CcSEcCtD
Rotigotine—Nausea—Irbesartan—type 2 diabetes mellitus	3.77e-05	0.00037	CcSEcCtD
Rotigotine—Rash—Losartan—type 2 diabetes mellitus	3.77e-05	0.00037	CcSEcCtD
Rotigotine—Dermatitis—Losartan—type 2 diabetes mellitus	3.77e-05	0.00037	CcSEcCtD
Rotigotine—Headache—Losartan—type 2 diabetes mellitus	3.75e-05	0.000368	CcSEcCtD
Rotigotine—Asthenia—Ramipril—type 2 diabetes mellitus	3.68e-05	0.000361	CcSEcCtD
Rotigotine—Pruritus—Ramipril—type 2 diabetes mellitus	3.63e-05	0.000356	CcSEcCtD
Rotigotine—Nausea—Losartan—type 2 diabetes mellitus	3.55e-05	0.000349	CcSEcCtD
Rotigotine—Diarrhoea—Ramipril—type 2 diabetes mellitus	3.51e-05	0.000344	CcSEcCtD
Rotigotine—Dizziness—Ramipril—type 2 diabetes mellitus	3.39e-05	0.000333	CcSEcCtD
Rotigotine—Vomiting—Ramipril—type 2 diabetes mellitus	3.26e-05	0.00032	CcSEcCtD
Rotigotine—Rash—Ramipril—type 2 diabetes mellitus	3.23e-05	0.000317	CcSEcCtD
Rotigotine—Dermatitis—Ramipril—type 2 diabetes mellitus	3.23e-05	0.000317	CcSEcCtD
Rotigotine—Headache—Ramipril—type 2 diabetes mellitus	3.21e-05	0.000315	CcSEcCtD
Rotigotine—Nausea—Ramipril—type 2 diabetes mellitus	3.05e-05	0.000299	CcSEcCtD
Rotigotine—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	2.78e-06	5.56e-05	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—SRC—type 2 diabetes mellitus	2.78e-06	5.55e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.77e-06	5.54e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.77e-06	5.54e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—CCR5—type 2 diabetes mellitus	2.77e-06	5.52e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.77e-06	5.52e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.76e-06	5.5e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.75e-06	5.5e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.74e-06	5.47e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.72e-06	5.43e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.72e-06	5.42e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	2.72e-06	5.42e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	2.71e-06	5.41e-05	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.71e-06	5.41e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.7e-06	5.4e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—C3—type 2 diabetes mellitus	2.7e-06	5.4e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—PRKCB—type 2 diabetes mellitus	2.7e-06	5.4e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	2.67e-06	5.33e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	2.67e-06	5.33e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—IRS1—type 2 diabetes mellitus	2.65e-06	5.29e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.62e-06	5.22e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	2.62e-06	5.22e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—RELA—type 2 diabetes mellitus	2.61e-06	5.21e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—PSMD6—type 2 diabetes mellitus	2.61e-06	5.21e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—SNAP25—type 2 diabetes mellitus	2.61e-06	5.21e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—SREBF1—type 2 diabetes mellitus	2.61e-06	5.21e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.58e-06	5.15e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	2.58e-06	5.15e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—IRS2—type 2 diabetes mellitus	2.57e-06	5.14e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—AGT—type 2 diabetes mellitus	2.57e-06	5.13e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—CTGF—type 2 diabetes mellitus	2.56e-06	5.11e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—IRS1—type 2 diabetes mellitus	2.56e-06	5.11e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—HMGCR—type 2 diabetes mellitus	2.54e-06	5.07e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—INS—type 2 diabetes mellitus	2.54e-06	5.07e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—CALM1—type 2 diabetes mellitus	2.53e-06	5.04e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	2.52e-06	5.03e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—APOE—type 2 diabetes mellitus	2.52e-06	5.03e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—LEP—type 2 diabetes mellitus	2.52e-06	5.03e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	2.5e-06	5e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.5e-06	4.99e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.5e-06	4.99e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.5e-06	4.98e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—APOA1—type 2 diabetes mellitus	2.49e-06	4.97e-05	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.49e-06	4.96e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—ADRA2A—type 2 diabetes mellitus	2.48e-06	4.96e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.46e-06	4.92e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.46e-06	4.92e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.45e-06	4.9e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.45e-06	4.9e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—INS—type 2 diabetes mellitus	2.45e-06	4.89e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.44e-06	4.88e-05	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.44e-06	4.87e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.41e-06	4.81e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—CYP2E1—type 2 diabetes mellitus	2.39e-06	4.76e-05	CbGpPWpGaD
Rotigotine—DRD4—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.38e-06	4.75e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	2.37e-06	4.74e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.37e-06	4.73e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.37e-06	4.73e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—SLC2A1—type 2 diabetes mellitus	2.36e-06	4.71e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.36e-06	4.71e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.36e-06	4.7e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—RELA—type 2 diabetes mellitus	2.35e-06	4.69e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	2.35e-06	4.69e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.34e-06	4.67e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.33e-06	4.65e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—RELA—type 2 diabetes mellitus	2.32e-06	4.63e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	2.3e-06	4.6e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	2.3e-06	4.6e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	2.3e-06	4.59e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.3e-06	4.59e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—CYP3A4—type 2 diabetes mellitus	2.3e-06	4.59e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	2.29e-06	4.57e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	2.29e-06	4.57e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—GCG—type 2 diabetes mellitus	2.26e-06	4.52e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—SLC2A4—type 2 diabetes mellitus	2.26e-06	4.52e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	2.26e-06	4.51e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	2.26e-06	4.51e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.25e-06	4.49e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—IRS1—type 2 diabetes mellitus	2.25e-06	4.48e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	2.24e-06	4.48e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	2.24e-06	4.48e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	2.24e-06	4.48e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	2.23e-06	4.45e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.23e-06	4.44e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.23e-06	4.44e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.23e-06	4.44e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.2e-06	4.4e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	2.19e-06	4.38e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	2.19e-06	4.37e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	2.17e-06	4.32e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.16e-06	4.31e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—INS—type 2 diabetes mellitus	2.15e-06	4.29e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.15e-06	4.29e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.15e-06	4.29e-05	CbGpPWpGaD
Rotigotine—DRD1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.14e-06	4.27e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	2.13e-06	4.26e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.12e-06	4.23e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.12e-06	4.22e-05	CbGpPWpGaD
Rotigotine—DRD3—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.11e-06	4.22e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.11e-06	4.21e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	2.09e-06	4.18e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—RELA—type 2 diabetes mellitus	2.09e-06	4.18e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.09e-06	4.18e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.08e-06	4.15e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.08e-06	4.15e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.08e-06	4.15e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.07e-06	4.13e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—SRC—type 2 diabetes mellitus	2.05e-06	4.1e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	2.05e-06	4.1e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	2.04e-06	4.08e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—RELA—type 2 diabetes mellitus	2.02e-06	4.04e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	2.01e-06	4.02e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	2.01e-06	4.02e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	2.01e-06	4.02e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—MMP9—type 2 diabetes mellitus	2e-06	4e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2e-06	3.99e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	1.99e-06	3.97e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.98e-06	3.96e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.98e-06	3.95e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	1.98e-06	3.95e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.98e-06	3.94e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	1.97e-06	3.92e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	1.96e-06	3.91e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.96e-06	3.91e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—GNB3—type 2 diabetes mellitus	1.95e-06	3.89e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.95e-06	3.89e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.94e-06	3.88e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—HMOX1—type 2 diabetes mellitus	1.94e-06	3.87e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.92e-06	3.83e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	1.92e-06	3.83e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—CAT—type 2 diabetes mellitus	1.91e-06	3.82e-05	CbGpPWpGaD
Rotigotine—ADRA2B—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.91e-06	3.81e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.89e-06	3.77e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	1.89e-06	3.77e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.89e-06	3.77e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.89e-06	3.77e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.88e-06	3.75e-05	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—IL6—type 2 diabetes mellitus	1.87e-06	3.74e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	1.86e-06	3.71e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	1.85e-06	3.7e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—SRC—type 2 diabetes mellitus	1.85e-06	3.69e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	1.84e-06	3.68e-05	CbGpPWpGaD
Rotigotine—HTR1A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.84e-06	3.68e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.83e-06	3.66e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.82e-06	3.64e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—SRC—type 2 diabetes mellitus	1.82e-06	3.64e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	1.82e-06	3.64e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	1.82e-06	3.64e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.81e-06	3.62e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	1.81e-06	3.61e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.8e-06	3.59e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.8e-06	3.59e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	1.79e-06	3.58e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.79e-06	3.56e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.78e-06	3.55e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—RELA—type 2 diabetes mellitus	1.78e-06	3.54e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	1.77e-06	3.54e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.77e-06	3.53e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	1.76e-06	3.52e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	1.76e-06	3.51e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	1.75e-06	3.49e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	1.75e-06	3.49e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	1.74e-06	3.47e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	1.74e-06	3.47e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	1.73e-06	3.46e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.73e-06	3.46e-05	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.73e-06	3.45e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.72e-06	3.44e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.71e-06	3.4e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	1.69e-06	3.37e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.67e-06	3.34e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	1.67e-06	3.32e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.65e-06	3.3e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—SRC—type 2 diabetes mellitus	1.65e-06	3.29e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.63e-06	3.25e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.62e-06	3.23e-05	CbGpPWpGaD
Rotigotine—DRD2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.62e-06	3.23e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.6e-06	3.2e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.6e-06	3.2e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	1.6e-06	3.19e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.6e-06	3.19e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.59e-06	3.18e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—SRC—type 2 diabetes mellitus	1.59e-06	3.17e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	1.57e-06	3.13e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.55e-06	3.09e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	1.53e-06	3.05e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	1.52e-06	3.03e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.51e-06	3.02e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.5e-06	3e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	1.5e-06	3e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	1.5e-06	3e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	1.5e-06	2.99e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.5e-06	2.99e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	1.49e-06	2.98e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	1.49e-06	2.97e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	1.48e-06	2.95e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.47e-06	2.94e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	1.47e-06	2.94e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.47e-06	2.93e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.44e-06	2.88e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	1.43e-06	2.86e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.42e-06	2.84e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	1.4e-06	2.79e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—SRC—type 2 diabetes mellitus	1.39e-06	2.79e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.39e-06	2.78e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—IL6—type 2 diabetes mellitus	1.38e-06	2.76e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	1.38e-06	2.75e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	1.37e-06	2.73e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.36e-06	2.71e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	1.34e-06	2.68e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	1.34e-06	2.67e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	1.32e-06	2.63e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	1.32e-06	2.63e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	1.3e-06	2.6e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	1.3e-06	2.59e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	1.29e-06	2.57e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.28e-06	2.55e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	1.27e-06	2.54e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.25e-06	2.49e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—IL6—type 2 diabetes mellitus	1.24e-06	2.49e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	1.23e-06	2.46e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—IL6—type 2 diabetes mellitus	1.23e-06	2.45e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.22e-06	2.44e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	1.21e-06	2.42e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	1.2e-06	2.4e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	1.17e-06	2.34e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	1.17e-06	2.33e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	1.15e-06	2.3e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.15e-06	2.29e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	1.15e-06	2.29e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	1.13e-06	2.27e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.13e-06	2.26e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	1.11e-06	2.23e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	1.11e-06	2.23e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—IL6—type 2 diabetes mellitus	1.11e-06	2.21e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—IL6—type 2 diabetes mellitus	1.07e-06	2.14e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.02e-06	2.04e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	1.02e-06	2.04e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	1e-06	2e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—AKT1—type 2 diabetes mellitus	9.87e-07	1.97e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	9.81e-07	1.96e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—IL6—type 2 diabetes mellitus	9.4e-07	1.88e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	8.99e-07	1.8e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—AKT1—type 2 diabetes mellitus	8.67e-07	1.73e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	8.6e-07	1.72e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	8.6e-07	1.72e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	7.87e-07	1.57e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	6.05e-07	1.21e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	5.12e-07	1.02e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	3.95e-07	7.89e-06	CbGpPWpGaD
